ForbesGroupon Cofounder’s Health Startup Hits $2 Billion Valuation With Latest Funding RoundAug 30, 2018CardiologyOncologyMedia CoverageRelated contentTempus Announces 37 Abstracts Accepted for Presentation at the 2026 American Society of Clinical Oncology Annual MeetingA Decade of Discovery: Tempus Supported Almost 1,500 Research Projects in 10 YearsTempus Announces Four Abstracts Accepted for Presentation at the 2024 San Antonio Breast Cancer Symposium